Author

Liming Peng

Observed name: L. Peng

Institutions: College of Sports Science and Technology of Wuhan Sports University, Wuhan Sports University

Observed institutions: General Administration of Sport of China, Sun Yat-sen University Cancer Center, College of Sports Science and Technology of Wuhan Sports University, Wuhan Sports University

ORCID: 0009-0002-8098-4646

Observed ORCID: 0009-0002-8098-4646

OpenAlex ID: A5002761361

Integration of machine learning XGBoost and SHAP models for NBA game outcome prediction and quantitative analysis methodology

2024 · Yan Ouyang, Xuewei Li, et al. · PLoS ONE · 59

Explaining basketball game performance with SHAP: insights from Chinese Basketball Association

2025 · Yan Ou-Yang, Wei Hong, et al. · Scientific Reports · 22

892P Camrelizumab plus dalpiciclib in anti-PD-1 refractory recurrent or metastatic nasopharyngeal carcinoma

2024 · X. Ding, Z. Feng, et al. · Annals of Oncology · 2

663P Camrelizumab plus apatinib in patients with recurrent or metastatic nasopharyngeal carcinoma failing first-line therapy: An open-label, single-arm, phase II study

2022 · X. Ding, W. Zhang, et al. · Annals of Oncology

Works count: 4

Citation count: 83

H-index: 2

I10-index: 2